Mobile Cancer Screening Act

S 2927, the Mobile Cancer Screening Act, creates a federal grant program to fund new mobile cancer screening units targeting rural and underserved communities. It provides up to $2 million per grant to eligible entities like community health centers and hospitals for purchasing vehicles, imaging equipment, and digital tools to expand access to screenings - particularly for lung and breast cancer. The program prioritizes areas with high cancer mortality rates, requires a 1:3 matching contribution from recipients, and mandates a report to Congress on screening outcomes by 2031. This directly aims to increase early cancer detection (when 5-year survival rates reach 63%) by addressing low current screening rates (4.5% for lung cancer in 2022).